Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Shuster

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1995
Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastomaD Strother, J J Shuster, N McWilliams, et al.
Leukemia|June 1, 2002
Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group studyS S Winter, J Sweatman, J J Shuster, et al.
Leukemia|September 20, 2000
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group StudyM B Harris, J J Shuster, J Pullen, et al.
Cancer Genetics and Cytogenetics|July 1, 1994
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493)M J Pettenati, N Rao, M Wofford, et al.
Veterinary Journal (London, England : 1997)|April 9, 2016
Infectious diseases in dogs rescued during dogfighting investigationsS H Cannon, J K Levy, S K Kirk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group studyV J Land, J J Shuster, W M Crist, et al.
Journal of Inherited Metabolic Disease|August 19, 2008
Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic controlA V Bernier, C P Sentner, C E Correia, et al.
Blood|February 1, 1996
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosisD I Marks, B W Kurz, M P Link, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group studyB Camitta, B Leventhal, S Lauer, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1995
Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastomaD Strother, J J Shuster, N McWilliams, et al.
Leukemia|June 1, 2002
Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group studyS S Winter, J Sweatman, J J Shuster, et al.
Leukemia|September 20, 2000
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group StudyM B Harris, J J Shuster, J Pullen, et al.
Cancer Genetics and Cytogenetics|July 1, 1994
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493)M J Pettenati, N Rao, M Wofford, et al.
Veterinary Journal (London, England : 1997)|April 9, 2016
Infectious diseases in dogs rescued during dogfighting investigationsS H Cannon, J K Levy, S K Kirk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group studyV J Land, J J Shuster, W M Crist, et al.
Journal of Inherited Metabolic Disease|August 19, 2008
Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic controlA V Bernier, C P Sentner, C E Correia, et al.
Blood|February 1, 1996
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosisD I Marks, B W Kurz, M P Link, et al.
Pageof 16